| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2020-2023 |
| Base Year |
2024 |
| Forecast Period |
2025-2032 |
| Dual Energy X-Ray Absorptiometry Market Size 2024 |
USD 640.88 million |
| Dual Energy X-Ray Absorptiometry Market , CAGR |
6.61% |
| Dual Energy X-Ray Absorptiometry Market Size 2032 |
USD 1,069.45 million |
Market Overview
The Dual Energy X-Ray Absorptiometry (DEXA) market is projected to grow from USD 640.88 million in 2024 to USD 1,069.45 million by 2032, at a compound annual growth rate (CAGR) of 6.61%.
The Dual Energy X-Ray Absorptiometry (DEXA) market is driven by the rising prevalence of osteoporosis, increasing awareness of bone health, and the growing demand for non-invasive diagnostic techniques. As healthcare providers seek more accurate and efficient tools for assessing bone density and body composition, DEXA’s ability to deliver precise results in a short time is a significant advantage. Additionally, the aging global population, combined with the surge in lifestyle-related health issues, further fuels the demand for DEXA services. Technological advancements, such as the integration of artificial intelligence and machine learning in DEXA systems, are enhancing the precision and efficiency of scans, making them more accessible to a broader patient base. Furthermore, the expansion of healthcare infrastructure, especially in emerging markets, is expected to contribute to market growth. As preventive healthcare becomes a priority, DEXA’s role in early detection of bone disorders and monitoring overall health will continue to drive its market growth.
The Dual Energy X-Ray Absorptiometry (DEXA) market exhibits significant growth across various regions. North America holds the largest market share, driven by advanced healthcare infrastructure and high awareness of bone health. Europe follows closely, with a strong demand for osteoporosis screening, particularly in aging populations. The Asia-Pacific region is rapidly expanding due to improved healthcare systems and growing awareness, with countries like China and India leading the charge. Latin America and the Middle East & Africa, while smaller markets, are experiencing gradual growth driven by healthcare improvements and increasing focus on preventive care. Key players such as F. Hoffmann-La Roche Ltd., Pfizer Inc., Eli Lilly and Company, and Merck & Co., Inc. are actively expanding their presence across these regions, enhancing market competition through innovations and strategic partnerships.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research!
Download Sample
Market Insights
- The DEXA market is projected to grow from USD 640.88 million in 2024 to USD 1,069.45 million by 2032, with a CAGR of 6.61%.
- Rising prevalence of osteoporosis and increasing awareness of bone health are key drivers of DEXA market growth.
- Non-invasive diagnostic techniques, such as DEXA, are gaining popularity for their accuracy and efficiency in assessing bone density and body composition.
- Technological advancements, including AI and machine learning integration, are improving the precision and accessibility of DEXA systems.
- Expansion of healthcare infrastructure, particularly in emerging markets, is contributing to the rising demand for DEXA technology.
- North America holds the largest market share (45%) in 2024, driven by high healthcare expenditure and advanced infrastructure.
- Europe and Asia-Pacific regions follow with 30% and 15% market shares in 2024, due to aging populations, rising awareness, and increasing demand for preventive healthcare.
Market Drivers
Rising Prevalence of Osteoporosis
One of the key drivers for the growth of the Dual Energy X-Ray Absorptiometry (DEXA) market is the increasing prevalence of osteoporosis and other bone-related disorders. Osteoporosis is a condition characterized by weakened bones that are more prone to fractures, and it affects a significant portion of the aging population. For instance, GE Healthcare’s Lunar iDXA system offers high-resolution images and precise body composition analysis, allowing for early detection of bone loss and fracture risk assessment. As the global population ages, the demand for reliable diagnostic tools for bone health has surged. DEXA scans are recognized for their ability to measure bone mineral density (BMD) with high accuracy, making them a critical tool for diagnosing osteoporosis and preventing fractures in high-risk individuals.
Growing Focus on Preventive Healthcare
The global shift towards preventive healthcare is another significant factor driving the DEXA market. With an increased focus on early diagnosis and prevention of diseases, individuals are seeking more comprehensive and non-invasive diagnostic options. For instance, FUJIFILM India recently introduced the FDX Visionary-DR machine, which integrates groundbreaking 3D-DXA technology to generate 3D models of the femur from routine bone-mineral-density images. DEXA scans provide an efficient way to assess bone density, detect early signs of bone-related issues, and monitor changes in bone health over time. As more people prioritize preventive measures to maintain long-term health, the demand for DEXA technology is expected to rise significantly.
Technological Advancements in DEXA Systems
Technological advancements in DEXA systems have played a critical role in expanding their applications and improving their accuracy. The integration of artificial intelligence (AI) and machine learning into DEXA technology has enhanced the precision and speed of scans, enabling healthcare providers to deliver quicker and more accurate results. These innovations also make DEXA systems more user-friendly and accessible to a wider range of healthcare facilities. As technology continues to evolve, the adoption of advanced DEXA systems is likely to accelerate across healthcare settings.
Expanding Healthcare Infrastructure in Emerging Markets
The expanding healthcare infrastructure in emerging markets is contributing to the growth of the DEXA market. As economies develop and healthcare systems improve, there is an increasing demand for advanced medical equipment, including DEXA scanners. These markets offer significant growth potential as rising healthcare awareness, improved access to medical services, and higher healthcare spending lead to the adoption of diagnostic tools like DEXA for bone health assessments. This trend is expected to drive the expansion of the DEXA market globally.
Market Trends
Integration of Artificial Intelligence and Machine Learning
A prominent trend in the Dual Energy X-Ray Absorptiometry (DEXA) market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into DEXA systems. These advancements enhance the accuracy and efficiency of bone density measurements by enabling automated analysis of scan results. AI algorithms can identify patterns and potential anomalies in the data that may not be easily detected by human interpretation, thus improving the overall diagnostic capabilities. For instance, a convolutional neural network-based Bone Strain Index developed for DEXA analysis reached a predictive accuracy of close to 80% with a sensitivity of 75% and a specificity of 84% in identifying patients at risk of further vertebral fractures. The incorporation of these technologies is also streamlining the workflow for healthcare providers, reducing the time needed for interpreting results and enabling quicker treatment decisions.
Shift Toward Body Composition Analysis
Another growing trend is the increasing use of DEXA technology for body composition analysis. While DEXA has long been used for bone density measurements, its ability to precisely assess fat and lean tissue mass has gained significant attention. As obesity rates rise globally, body composition analysis is becoming an essential tool for evaluating overall health and assessing risks for conditions such as cardiovascular diseases and diabetes. For instance, Hologic’s Horizon DXA system, which is used for evaluating bone density and other body composition assessments. This shift broadens the applications of DEXA beyond bone health, making it a valuable diagnostic tool for a wider range of medical conditions.
Miniaturization and Portability of DEXA Systems
The trend toward miniaturization and the development of portable DEXA systems is helping to expand the accessibility of bone health diagnostics. Traditional DEXA machines are often large and require specialized clinical environments, but new portable and compact systems are enabling use in diverse healthcare settings, including outpatient clinics, mobile health units, and even home-based care. This trend is making DEXA scans more accessible to patients in remote or underserved areas, allowing for early detection and more personalized treatment plans.
Rising Demand for Preventive Healthcare
The increasing focus on preventive healthcare is driving the demand for DEXA scans as part of routine health assessments. As awareness about the importance of early detection of bone health issues grows, individuals are increasingly seeking non-invasive, reliable diagnostic options like DEXA to monitor bone density and overall health. This trend is particularly prevalent among older adults and individuals at risk for osteoporosis, fueling the overall growth of the DEXA market.
Market Challenges Analysis
High Cost of DEXA Systems and Maintenance
One of the significant challenges facing the Dual Energy X-Ray Absorptiometry (DEXA) market is the high cost associated with purchasing and maintaining DEXA systems. These advanced diagnostic tools often require a substantial initial investment, which may limit their adoption in smaller healthcare facilities or regions with lower healthcare budgets. Additionally, the ongoing maintenance, calibration, and potential repair of DEXA equipment can be expensive, further increasing the financial burden for healthcare providers. This challenge is particularly evident in emerging markets, where healthcare systems are still developing and may struggle to afford the necessary infrastructure for advanced diagnostic technologies like DEXA. As a result, while the benefits of DEXA scans are clear, the associated costs can hinder widespread adoption, especially in resource-constrained settings. Over time, this financial obstacle could slow down the growth of the market, limiting its potential to expand into various clinical and preventive healthcare applications.
Regulatory and Reimbursement Issues
Another challenge impacting the growth of the DEXA market is the complexity of regulatory approvals and reimbursement policies. In many regions, obtaining regulatory approval for new DEXA technologies can be a lengthy and costly process, which may delay the introduction of innovative products to the market. Furthermore, reimbursement policies for DEXA scans vary significantly by country and healthcare system, leading to uncertainties around the financial viability of these diagnostic procedures. For instance, Hologic Inc., another key player in the DEXA equipment market, has been actively working on improving imaging accuracy and promoting software integration in their DEXA systems. In some areas, limited reimbursement for DEXA scans may discourage healthcare providers from investing in the technology, as they may not be able to recover the costs through insurance claims. These regulatory and reimbursement hurdles pose significant barriers to the broader adoption of DEXA systems and the continued growth of the market. Moreover, inconsistent policies can create confusion among healthcare providers and patients, reducing the overall demand for DEXA services and affecting market expansion.
Market Opportunities
The growing global demand for preventive healthcare presents a significant opportunity for the Dual Energy X-Ray Absorptiometry (DEXA) market. As awareness of the importance of early detection of bone-related diseases, particularly osteoporosis, increases, more individuals are seeking reliable diagnostic tools. DEXA scans, known for their accuracy in measuring bone mineral density, offer an effective solution for monitoring bone health. With the rising aging population worldwide, the demand for osteoporosis screening and fracture prevention is expected to grow substantially. Furthermore, the expanding focus on body composition analysis, which can be assessed using DEXA, opens new avenues for the technology’s application in weight management, metabolic health, and other areas of preventive medicine.
Emerging markets also offer significant growth opportunities for the DEXA market. As healthcare infrastructure continues to improve in regions such as Asia-Pacific, Latin America, and the Middle East, the adoption of advanced diagnostic tools like DEXA is increasing. These markets are witnessing a rising incidence of lifestyle-related diseases, such as obesity and diabetes, which can be effectively managed through body composition analysis provided by DEXA scans. The increasing availability of affordable, portable DEXA systems further facilitates the expansion of this technology into smaller clinics, outpatient centers, and mobile health units, making it accessible to a broader patient population. With the right investments in technology and healthcare infrastructure, the DEXA market has the potential to significantly expand its reach and impact globally.
Market Segmentation Analysis:
By Type
The DEXA market is segmented based on the type of device, including portable and fixed systems. Portable DEXA systems are gaining popularity due to their convenience and ability to provide quick results in various healthcare settings, such as outpatient clinics and mobile units. Fixed systems remain dominant in hospitals and research institutions due to their high precision and advanced features.
By Therapy Type
In terms of therapy type, the DEXA market is primarily driven by the use of diagnostic procedures for bone health, including osteoporosis screening and fracture risk assessments. DEXA scans are also increasingly utilized in body composition analysis for managing obesity and metabolic diseases. The growing focus on preventive healthcare has led to greater demand in both these therapy areas.
By Dosage Form
The DEXA market is less influenced by dosage forms, as it is a diagnostic tool rather than a pharmaceutical product. However, it plays a crucial role in determining the appropriate therapeutic dosage for patients undergoing treatments related to bone health, particularly in monitoring the effectiveness of osteoporosis medications and therapies.
Segments:
Based on Type:
- Leukaemia
- Lymphoma
- Myeloma
Based on Therapy Type
- Chemotherapy
- Immunotherapy
- Targeted Therapy
-
- Tyrosine kinase inhibitors
- Proteasome inhibitor
- B-cell lymphoma-2 protein inhibitor
- Isocitrate dehydrogenase-1 inhibitor
- Hedgehog pathway inhibitor
- Others
Based on Diagnosis
- Blood Tests
- Biopsy
- Imaging Tests
-
- X-ray
- Magnetic resonance imaging (MRI)
- Positron Emission Tomography (PET)
Based on Dosage form
- Tablets
- Capsules
- Injections
- Others
Based on Route of Administration
Based on End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Based on the Geography:
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Regional Analysis
North America
North America holds the largest share of the Dual Energy X-Ray Absorptiometry (DEXA) market, accounting for 45% of the global market in 2024. This dominance can be attributed to the high healthcare expenditure, advanced healthcare infrastructure, and the growing prevalence of osteoporosis among the aging population in the region. The United States, in particular, is a significant contributor to the market share, driven by the widespread adoption of advanced diagnostic technologies. The increasing awareness about bone health, coupled with government initiatives to promote preventive healthcare, has led to a higher demand for DEXA scans. Additionally, the presence of key market players and continuous technological innovations further strengthen North America’s position in the DEXA market.
Europe
Europe holds a substantial portion of the DEXA market, accounting for 30% of the global share in 2024. The region benefits from an aging population and the rising incidence of bone-related diseases, such as osteoporosis, particularly in countries like Germany, France, and the United Kingdom. European healthcare systems are increasingly adopting advanced diagnostic tools, and there is a growing demand for early detection and preventive healthcare solutions. The introduction of portable DEXA systems is also contributing to market growth in Europe, allowing for greater accessibility in both urban and rural areas. Government-funded health programs and the ongoing focus on improving healthcare delivery further bolster the market in this region.
Asia-Pacific
The Asia-Pacific region is witnessing rapid growth in the DEXA market, holding a 15% share in 2024. The region’s expanding healthcare infrastructure, coupled with an increasing awareness of bone health, is driving the adoption of DEXA systems. Countries like Japan, China, and India are experiencing significant demand due to the rising aging population and the growing prevalence of lifestyle diseases, such as obesity, which can be assessed using body composition analysis via DEXA. Additionally, technological advancements and the availability of affordable portable systems are making DEXA more accessible in emerging markets, further contributing to the region’s growth.
Latin America
Latin America accounts for 5% of the global DEXA market in 2024. The market is driven by the increasing adoption of advanced diagnostic technologies in countries like Brazil and Mexico, where healthcare systems are improving and the demand for osteoporosis screening is on the rise. However, the high cost of DEXA systems and limited reimbursement policies pose challenges to broader adoption. Despite these hurdles, the increasing focus on preventive healthcare and rising awareness of bone health are expected to drive the market’s growth in the coming years.
Middle East & Africa
The Middle East and Africa region holds a smaller share of the DEXA market, accounting for 5% in 2024. However, the region is witnessing gradual growth, particularly in the Middle Eastern countries with expanding healthcare sectors. The demand for DEXA scans is rising due to the growing focus on preventive healthcare and the increasing incidence of osteoporosis, especially in the aging population. The region’s market growth is further supported by healthcare infrastructure improvements and rising awareness about bone health.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key Player Analysis
- Eli Lilly and Company (US)
- Bayer AG (Germany)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Hoffmann-La Roche Ltd. (Switzerland)
- Pfizer Inc. (US)
- Novartis AG (Switzerland)
- Allergan (Ireland)
- AstraZeneca (UK)
- GlaxoSmithKline plc (UK)
- Merck & Co., Inc. (US)
- Mylan N.V. (US)
- Sanofi (France)
Competitive Analysis
The Dual Energy X-Ray Absorptiometry (DEXA) market is highly competitive, with leading players like F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, Eli Lilly and Company, Merck & Co., Inc., Allergan, and AstraZeneca driving market dynamics. These companies are actively investing in technological innovations, enhancing the precision and functionality of DEXA systems to meet the increasing demand for bone health assessments. They focus on expanding product portfolios, offering portable and advanced DEXA systems that cater to diverse healthcare settings, including outpatient clinics and mobile health units. Strategic partnerships, mergers, and acquisitions are also common strategies to maintain a competitive edge. The companies are concentrating on gaining regulatory approvals and improving reimbursement policies to boost market penetration, especially in emerging markets. With a continued focus on technological advancements and expanding regional reach, these players are well-positioned to drive growth in the evolving DEXA market.
Recent Developments
- In February 2025, Sanofi announced positive results from a phase 3 study of their drug duvakitug for ulcerative colitis and Crohn’s disease.
Market Concentration & Characteristics
The Dual Energy X-Ray Absorptiometry (DEXA) market exhibits moderate concentration, with a few key players dominating the landscape, while several regional and emerging companies contribute to its growth. The market is characterized by technological advancements, particularly the integration of artificial intelligence (AI) and machine learning, which enhances the precision and efficiency of DEXA systems. Leading companies focus on continuous innovation and the expansion of their product portfolios to cater to diverse healthcare needs. Moreover, there is a strong emphasis on portability, enabling DEXA systems to be used in various settings, including mobile units and smaller clinics. The market also demonstrates a trend toward strategic partnerships, acquisitions, and mergers to strengthen market presence and expand regional footprints. While the market is predominantly led by a few established players, the growing demand for advanced diagnostic solutions continues to attract new entrants, contributing to increased competition and innovation in the sector.
Report Coverage
The research report offers an in-depth analysis based on Type, Therapy Type, Diagnosis, Dosage Form, Route of Administration, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
- The DEXA market will continue to expand as demand for accurate and non-invasive diagnostic tools rises.
- Technological innovations, such as AI and machine learning integration, will further enhance the efficiency and precision of DEXA systems.
- Portable DEXA systems will become more prevalent, providing increased accessibility in outpatient clinics and mobile healthcare units.
- The growing global aging population will drive the need for osteoporosis screening and other bone health assessments.
- Preventive healthcare trends will significantly contribute to the increasing adoption of DEXA systems worldwide.
- Emerging markets in regions like Asia-Pacific, Latin America, and the Middle East will see substantial growth due to improving healthcare infrastructure.
- The introduction of cost-effective DEXA systems will increase adoption in resource-constrained settings.
- Market players will focus on expanding product portfolios to address the diverse needs of healthcare providers and patients.
- Strategic partnerships and collaborations will play a key role in expanding market presence and regional reach.
- The increasing awareness of bone health and body composition will drive demand for DEXA technology in both clinical and wellness sectors.
